142 related articles for article (PubMed ID: 33438471)
1. Achieving effective and selective CK1 inhibitors through structure modification.
Du C; Yang H; Feng F; Liu W; Chen Y; Sun H
Future Med Chem; 2021 Mar; 13(5):505-528. PubMed ID: 33438471
[TBL] [Abstract][Full Text] [Related]
2. 2-Phenylamino-6-cyano-1H-benzimidazole-based isoform selective casein kinase 1 gamma (CK1γ) inhibitors.
Hua Z; Huang X; Bregman H; Chakka N; DiMauro EF; Doherty EM; Goldstein J; Gunaydin H; Huang H; Mercede S; Newcomb J; Patel VF; Turci SM; Yan J; Wilson C; Martin MW
Bioorg Med Chem Lett; 2012 Sep; 22(17):5392-5. PubMed ID: 22877629
[TBL] [Abstract][Full Text] [Related]
3. Small molecule modulators targeting protein kinase CK1 and CK2.
Qiao Y; Chen T; Yang H; Chen Y; Lin H; Qu W; Feng F; Liu W; Guo Q; Liu Z; Sun H
Eur J Med Chem; 2019 Nov; 181():111581. PubMed ID: 31400711
[TBL] [Abstract][Full Text] [Related]
4. Recent Advances in the Development of Casein Kinase 1 Inhibitors.
Li SS; Dong YH; Liu ZP
Curr Med Chem; 2021; 28(8):1585-1604. PubMed ID: 32660395
[TBL] [Abstract][Full Text] [Related]
5. Inhibitors of casein kinase 1 block the growth of Leishmania major promastigotes in vitro.
Allocco JJ; Donald R; Zhong T; Lee A; Tang YS; Hendrickson RC; Liberator P; Nare B
Int J Parasitol; 2006 Oct; 36(12):1249-59. PubMed ID: 16890941
[TBL] [Abstract][Full Text] [Related]
6. 1-(Benzo[d]thiazol-2-yl)-3-phenylureas as dual inhibitors of casein kinase 1 and ABAD enzymes for treatment of neurodegenerative disorders.
Benek O; Hroch L; Aitken L; Gunn-Moore F; Vinklarova L; Kuca K; Perez DI; Perez C; Martinez A; Fisar Z; Musilek K
J Enzyme Inhib Med Chem; 2018 Dec; 33(1):665-670. PubMed ID: 29536773
[TBL] [Abstract][Full Text] [Related]
7. Casein kinases as potential therapeutic targets.
Cozza G; Pinna LA
Expert Opin Ther Targets; 2016; 20(3):319-40. PubMed ID: 26565594
[TBL] [Abstract][Full Text] [Related]
8. The role of the casein kinase 1 (CK1) family in different signaling pathways linked to cancer development.
Knippschild U; Wolff S; Giamas G; Brockschmidt C; Wittau M; Würl PU; Eismann T; Stöter M
Onkologie; 2005 Oct; 28(10):508-14. PubMed ID: 16186692
[TBL] [Abstract][Full Text] [Related]
9. Casein Kinase 1δ Inhibitors as Promising Therapeutic Agents for Neurodegenerative Disorders.
Catarzi D; Varano F; Vigiani E; Lambertucci C; Spinaci A; Volpini R; Colotta V
Curr Med Chem; 2022; 29(27):4698-4737. PubMed ID: 35232339
[TBL] [Abstract][Full Text] [Related]
10. Targeting Casein Kinase 1 (CK1) in Hematological Cancers.
Janovská P; Normant E; Miskin H; Bryja V
Int J Mol Sci; 2020 Nov; 21(23):. PubMed ID: 33261128
[TBL] [Abstract][Full Text] [Related]
11. The DUF1669 domain of FAM83 family proteins anchor casein kinase 1 isoforms.
Fulcher LJ; Bozatzi P; Tachie-Menson T; Wu KZL; Cummins TD; Bufton JC; Pinkas DM; Dunbar K; Shrestha S; Wood NT; Weidlich S; Macartney TJ; Varghese J; Gourlay R; Campbell DG; Dingwell KS; Smith JC; Bullock AN; Sapkota GP
Sci Signal; 2018 May; 11(531):. PubMed ID: 29789297
[TBL] [Abstract][Full Text] [Related]
12. Discovery of Potent and Exquisitely Selective Inhibitors of Kinase CK1 with Tunable Isoform Selectivity.
Němec V; Khirsariya P; Janovská P; Moyano PM; Maier L; Procházková P; Kebková P; Gybel' T; Berger BT; Chaikuad A; Reinecke M; Kuster B; Knapp S; Bryja V; Paruch K
Angew Chem Int Ed Engl; 2023 Mar; 62(11):e202217532. PubMed ID: 36625768
[TBL] [Abstract][Full Text] [Related]
13. The casein kinase 1 family: participation in multiple cellular processes in eukaryotes.
Knippschild U; Gocht A; Wolff S; Huber N; Löhler J; Stöter M
Cell Signal; 2005 Jun; 17(6):675-89. PubMed ID: 15722192
[TBL] [Abstract][Full Text] [Related]
14. Casein kinase 1: Complexity in the family.
Cheong JK; Virshup DM
Int J Biochem Cell Biol; 2011 Apr; 43(4):465-9. PubMed ID: 21145983
[TBL] [Abstract][Full Text] [Related]
15. A comparative study of structural and conformational properties of casein kinase-1 isoforms: insights from molecular dynamics and principal component analysis.
Singh SP; Gupta DK
J Theor Biol; 2015 Apr; 371():59-68. PubMed ID: 25665722
[TBL] [Abstract][Full Text] [Related]
16. Optimized 4,5-Diarylimidazoles as Potent/Selective Inhibitors of Protein Kinase CK1δ and Their Structural Relation to p38α MAPK.
Halekotte J; Witt L; Ianes C; Krüger M; Bührmann M; Rauh D; Pichlo C; Brunstein E; Luxenburger A; Baumann U; Knippschild U; Bischof J; Peifer C
Molecules; 2017 Mar; 22(4):. PubMed ID: 28338621
[TBL] [Abstract][Full Text] [Related]
17. CK1 in Developmental Signaling: Hedgehog and Wnt.
Jiang J
Curr Top Dev Biol; 2017; 123():303-329. PubMed ID: 28236970
[TBL] [Abstract][Full Text] [Related]
18. Functions and regulation of the serine/threonine protein kinase CK1 family: moving beyond promiscuity.
Fulcher LJ; Sapkota GP
Biochem J; 2020 Dec; 477(23):4603-4621. PubMed ID: 33306089
[TBL] [Abstract][Full Text] [Related]
19. Identification of novel protein kinase CK1 delta (CK1delta) inhibitors through structure-based virtual screening.
Cozza G; Gianoncelli A; Montopoli M; Caparrotta L; Venerando A; Meggio F; Pinna LA; Zagotto G; Moro S
Bioorg Med Chem Lett; 2008 Oct; 18(20):5672-5. PubMed ID: 18799313
[TBL] [Abstract][Full Text] [Related]
20. In vitro identification of imidazo[1,2-a]pyrazine-based antileishmanial agents and evaluation of L. major casein kinase 1 inhibition.
Bazin MA; Cojean S; Pagniez F; Bernadat G; Cavé C; Ourliac-Garnier I; Nourrisson MR; Morgado C; Picot C; Leclercq O; Baratte B; Robert T; Späth GF; Rachidi N; Bach S; Loiseau PM; Le Pape P; Marchand P
Eur J Med Chem; 2021 Jan; 210():112956. PubMed ID: 33148491
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
